The present invention relates to a Drosophila in vitro system which was used to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore …
The present invention relates to a Drosophila in vitro System which was used to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Further more …
D Morrissey, J McSwiggen… - US Patent App. 10 …, 2003 - Google Patents
The present invention concerns methods and reagents useful in modulating hepatitis B virus (HBV) gene expression in a variety of applications, including use in therapeutic, diag nostic …
JJ Rossi, MA Behlke, D Kim - US Patent 8,084,599, 2011 - Google Patents
The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as for treating …
J McSwiggen - US Patent App. 10/205,309, 2003 - Google Patents
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target …
YX Li, M Farrell, M Kirby - US Patent App. 10/038,984, 2002 - Google Patents
US20020114784A1 - Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA - Google Patents US20020114784A1 …
D Brown, L Ford, R Jarvis - US Patent App. 10/298,480, 2004 - Google Patents
The present invention concerns methods and compositions involving the production or generation of siRNA mixtures or pools capable of triggering RNA-mediated interference …